Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLICK: Chlorthalidone in Chronic Kidney Disease
NCT02841280Phase 2Completed
- Sponsor
- Indiana University
- Start
- Jul 2016
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of chlorthalidone in hypertension (HTN), sponsored by Indiana University. Primary endpoint: Change From Baseline to 12 Weeks in Systolic Ambulatory Blood Pressure. Started Jul 2016; status: completed.
02
Drugs
chlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02841280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02841280.